Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.24 | 18.43 |
| PEG Ratio (TTM) | 0.01 | 1.94 |
| P/S Ratio (TTM) | 0.54 | 6.56 |
| P/B Ratio (TTM) | 0.56 | 5.29 |
| P/FCF Ratio (TTM) | -0.47 | 18.13 |
| Price to 5YR AVG Earnings Ratio | N/A | 107.44 |
| Price to 5YR AVG FCF Ratio | N/A | 45.92 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -119.31% | -0.54% |
| ROE (TTM) | -171.34% | 12.91% |
| Net Profit Margin (TTM) | -237.77% | 0.57% |
| ROIC 5YR AVG | N/A | 10.30% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -210.51% | -14.90% | N/A |
| Revenue | -8.19% | 18.28% | N/A |
| Net Income | -13.60% | -29.73% | N/A |
| Cash Flow | -14.55% | -81.72% | N/A |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.17 | 2.80 |
| Quick Ratio (TTM) | 1.17 | 2.69 |
| D/E Ratio (TTM) | 0.70 | 0.73 |
| Interest Coverage (TTM) | -2.27 | 2.80 |
| Piotroski F-Score | 5 | 5 |
| Altman Z-Score | N/A | 9.33 |
| LTL to 5YR AVG FCF | N/A | 2.40 |
| Shares Outstanding Growth 5YR AVG | N/A | 23.77% |